Cytosorbents (CTSO) Other Accumulated Expenses (2018 - 2026)
Cytosorbents' (CTSO) quarterly Other Accumulated Expenses came in at $268000.0 in Q1 2026, down 66.37% YoY from $796925.0 in Q1 2025, and down 1.11% on a QoQ basis from $271000.0 in Q4 2025.
Cytosorbents (CTSO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 9 years of Other Accumulated Expenses data on file, last reported at $268000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 66.37% year-over-year to $268000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268000.0 (down 66.37% YoY) and the FY2025 annual result came in at $271000.0, down 1.45% from the prior year.
- Other Accumulated Expenses retreated to $268000.0 in Q1 2026, from $271000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $991545.0 in Q4 2023 to a low of $268000.0 in Q1 2026.
- A 5-year average of $470483.5 and a median of $284500.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 67.38% — and 2024, when it slumped 72.27%.
- Tracing CTSO's Other Accumulated Expenses over 5 years: stood at $592398.0 in 2022, then surged by 67.38% to $991545.0 in 2023, then tumbled by 72.27% to $275000.0 in 2024, then decreased by 1.45% to $271000.0 in 2025, then decreased by 1.11% to $268000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $268000.0 (Q1 2026), $271000.0 (Q4 2025), and $282000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 558,000.00 |
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 796,925.00 |
| Dec 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 991,545.00 |
| Dec 31, 2022 | 592,398.00 |
| Dec 31, 2021 | 769,262.00 |
| Dec 31, 2020 | 916,695.00 |
| Dec 31, 2019 | 525,004.00 |
| Dec 31, 2018 | 433,589.00 |